4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-065222
President & CEO sold 42,773 shares at $13.16 ($562,893)
- President & CEO acquired 94,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2021-11-15 | Grant or award | +94,100 | 518,223 | D: show line 1 in the form | ||
| ROBIN HOWARD W President & CEO | 2021-11-16 | Sale | −42,773 | $13.16 | $562,893 | 475,450 | D: show line 2 in the form |
| Open-market sales · 42,773 sh · avg $13.16 · $562,893 | |||||||
Loading xslF345X03/doc4.xml…